J3316
HCPCSInj., triptorelin xr 3.75 mg
Official HCPCS Level II long descriptor
Injection, triptorelin, extended-release, 3.75 mg
HCPCS Level II code J3316 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj., triptorelin xr 3.75 mg
Added to HCPCS: 2019-01-01
Nearby codes in J3
- J3291Tranexamic acid in sod chlor
- J3299Inj xipere 1 mg
- J3300Triamcinolone a inj prs-free
- J3301Triamcinolone acet inj nos
- J3302Triamcinolone diacetate inj
- J3303Triamcinolone hexacetonl inj
- J3304Inj triamcinolone ace xr 1mg
- J3315Triptorelin pamoate
- J3350Urea injection
- J3357Ustekinumab sub cu inj, 1 mg
- J3358Ustekinumab, iv inject, 1 mg
- J3360Diazepam injection
- J3373Inj, vancomycin hcl, 10 mg
- J3374Inj, vancomycin (mylan) 10mg
- J3375Inj, vanco (tyzavan) 10mg
- J3376Inj vancomycin (hikma) 10mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.